TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc
Abstract The proliferation of bladder cancer (BC) cells is driven by metabolic reprogramming, marked by a glycolytic dependency to sustain uncontrolled growth. While Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) is known to promote BC progression and correlate with poor prognosis, the...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07645-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849699078535905280 |
|---|---|
| author | Zhirui Lin Falian Liang Gengde Hong Xizhen Jiang Qingling Zhang Mengyao Wang |
| author_facet | Zhirui Lin Falian Liang Gengde Hong Xizhen Jiang Qingling Zhang Mengyao Wang |
| author_sort | Zhirui Lin |
| collection | DOAJ |
| description | Abstract The proliferation of bladder cancer (BC) cells is driven by metabolic reprogramming, marked by a glycolytic dependency to sustain uncontrolled growth. While Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) is known to promote BC progression and correlate with poor prognosis, the mechanisms underlying its upregulation and role in aerobic glycolysis remain unclear. Here, we identify E2F3 as a direct transcriptional activator of TACC3, with its amplification in BC driving elevated TACC3 expression. TACC3 overexpression enhances glycolysis, increasing glucose consumption, lactate production, and expression of glycolytic enzymes (e.g., GLUT1, HK2, PFKFB3), while its knockdown suppresses these effects. Pharmacological inhibition of glycolysis abrogates TACC3-driven tumor growth in vitro and in vivo. Mechanistically, TACC3 interacts with c-Myc, promoting its acetylation at lysine 323 (K323) by recruiting the acetyltransferase PCAF and antagonizing the deacetylase SIRT1. This acetylation stabilizes c-Myc, amplifying its transcriptional activation of glycolytic targets. Our findings establish TACC3 as a critical regulator of c-Myc-driven metabolic reprogramming in BC, highlighting its potential as a therapeutic target to disrupt glycolysis and oncogenic c-Myc signaling. |
| format | Article |
| id | doaj-art-db3f3a8899ea418b850b3a0a1b508ddb |
| institution | DOAJ |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-db3f3a8899ea418b850b3a0a1b508ddb2025-08-20T03:18:42ZengNature Publishing GroupCell Death and Disease2041-48892025-04-0116111210.1038/s41419-025-07645-6TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-MycZhirui Lin0Falian Liang1Gengde Hong2Xizhen Jiang3Qingling Zhang4Mengyao Wang5Institute of Medical Research, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical UniversityRadiation Oncology Department, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityRadiation Oncology Department, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityRadiation Oncology Department, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityDepartment of Pathology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical UniversityRadiation Oncology Department, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityAbstract The proliferation of bladder cancer (BC) cells is driven by metabolic reprogramming, marked by a glycolytic dependency to sustain uncontrolled growth. While Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) is known to promote BC progression and correlate with poor prognosis, the mechanisms underlying its upregulation and role in aerobic glycolysis remain unclear. Here, we identify E2F3 as a direct transcriptional activator of TACC3, with its amplification in BC driving elevated TACC3 expression. TACC3 overexpression enhances glycolysis, increasing glucose consumption, lactate production, and expression of glycolytic enzymes (e.g., GLUT1, HK2, PFKFB3), while its knockdown suppresses these effects. Pharmacological inhibition of glycolysis abrogates TACC3-driven tumor growth in vitro and in vivo. Mechanistically, TACC3 interacts with c-Myc, promoting its acetylation at lysine 323 (K323) by recruiting the acetyltransferase PCAF and antagonizing the deacetylase SIRT1. This acetylation stabilizes c-Myc, amplifying its transcriptional activation of glycolytic targets. Our findings establish TACC3 as a critical regulator of c-Myc-driven metabolic reprogramming in BC, highlighting its potential as a therapeutic target to disrupt glycolysis and oncogenic c-Myc signaling.https://doi.org/10.1038/s41419-025-07645-6 |
| spellingShingle | Zhirui Lin Falian Liang Gengde Hong Xizhen Jiang Qingling Zhang Mengyao Wang TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc Cell Death and Disease |
| title | TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc |
| title_full | TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc |
| title_fullStr | TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc |
| title_full_unstemmed | TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc |
| title_short | TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc |
| title_sort | tacc3 enhances glycolysis in bladder cancer cells through inducing acetylation of c myc |
| url | https://doi.org/10.1038/s41419-025-07645-6 |
| work_keys_str_mv | AT zhiruilin tacc3enhancesglycolysisinbladdercancercellsthroughinducingacetylationofcmyc AT falianliang tacc3enhancesglycolysisinbladdercancercellsthroughinducingacetylationofcmyc AT gengdehong tacc3enhancesglycolysisinbladdercancercellsthroughinducingacetylationofcmyc AT xizhenjiang tacc3enhancesglycolysisinbladdercancercellsthroughinducingacetylationofcmyc AT qinglingzhang tacc3enhancesglycolysisinbladdercancercellsthroughinducingacetylationofcmyc AT mengyaowang tacc3enhancesglycolysisinbladdercancercellsthroughinducingacetylationofcmyc |